Increased bone fracture is one of the health risk factors in patients with bone loss related disorders such as osteoporosis and breast cancer metastasis to bone. Over activity of osteoclasts leads to uncoupling of bone remodeling favoring bone loss over bone formation. Receptor activator of nuclear factor-κβ ligand (RANKL) triggers the differentiation pathway leading to multinucleated osteoclast formation. Modulation of RANKL or its downstream signaling pathways involved in osteoclast formation is of significant interest in the development of anti-resorptive agents. In this study, we investigated the effects of piperine, an alkaloid present in Piper nigrum L. on osteoclast formation. Piperine inhibited tartrate-resistant acid phosphatase (TRAP)-positive multinucleated osteoclast formation in murine RAW264.7 macrophages and human CD14+ monocytes induced by RANKL and breast cancer cells. Piperine attenuated the p38-mitogen activated protein kinase (MAPK) pathway activation, while the extracellular-signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) or NF-κβ pathways downstream of RANKL remained unaffected. Concomitantly, expression of c-Fos and nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1), the key transcription factors involved in osteoclastogenesis were remarkably inhibited by piperine. Furthermore, piperine disrupted the actin ring structure and bone resorption, a characteristic hallmark of osteoclasts. Collectively, these results suggest that piperine inhibits osteoclast differentiation by suppressing the p38/NFATc1/c-Fos signaling axis.
Introduction
Osteoclasts are specialized bone resorbing multinucleated cells derived from hematopoietic cells of the monocyte/macrophage lineage (1) . The receptor activator of nuclear factor kappa-β (RANK) and its ligand (RANKL) are key molecules involved in differentiation and activation of osteoclasts from precursor cells (2) . On the other hand, osteoblasts arising from progenitor cells of the mesenchymal lineage are responsible for bone formation and mineral deposition (3) . The interplay among osteoblasts and osteoclasts are coupled in a manner that the processes of bone formation and bone resorption termed bone remodeling does not supersede each other.
Intriguingly, bone remodeling is often aggravated during certain diseases such as osteoporosis, cancer metastasis to bone, rheumatoid and osteo-arthritis (4, 5) . Excessive bone loss as seen in aforementioned pathological conditions correlate either with elevated osteoclast formation or augmented osteoclast activity. In line with this, ageing also constitutes to the negative effects seen in bone-loss related diseases as stemness and differentiation potential of mesenchymal progenitors towards osteoblast lineage is afflicted (6, 7) .
RANKL and its receptor RANK are key factors involved in the initiation of osteoclast formation (8) . RANKL, a member of the tumor necrosis factor (TNF) family triggers the formation of osteoclasts and plays an important role in their survival (8) . RANKL is produced in membrane-bound form by cells of osteoblast lineage and activated T-cells (9) . Both, the soluble as well as membrane bound form of RANKL are produced by activated T-cells and certain type of cancer cells (prostate-and breast cancer), although production of soluble RANKL indicates pathological conditions (9) (10) (11) .
In the bone microenvironment, physical interaction between osteoblasts and osteoclast precursors activates RANK resulting in initiation of the downstream signaling cascade involved in osteoclast formation. During rheumatoid arthritis, production of soluble RANKL by activated T-lymphocytes can also trigger osteoclastogenesis from osteoclast precursors causing joint destruction (12) . Osteoblasts also produce and secrete a decoy receptor of RANK, osteoprotegerin (OPG) (2) . The decoy receptor binds to all forms of RANKL and neutralizes its functions.
The RANKL/RANK/OPG system is instrumental in bone remodeling.
Macrophage-colony stimulating factor (M-CSF) is a cytokine produced by various cells including osteoblasts and acts in a paracrine manner to maintain the survival and proliferation of osteoclast progenitors (13) . Trimerization of RANK occurs when RANKL binds to the receptor leading a subsequent step that involves binding to an adaptor molecule, TNF receptor-associated factor 6 (TRAF6) (14) . This activates a sequential chain of events comprising activation of IκBα/β kinase (IKK), NF-κβ, MAPKs, c-Fos and NFATc1 resulting in osteoclast formation.
Since, RANKL-induced signaling pathway is critical for osteoclast formation, attenuation of RANKL or effectors downstream of RANKL is a promising therapeutic option against osteoclastogenesis (15) . As reported by Newman et al, approximately 48.6% of currently approved drugs by FDA are either natural products or are directly derived from them and thereby serve as an essential source of lead compounds (16) . Piperine is one of the major constituents of black pepper, Piper nigrum Linn. and long pepper, Piper longum Linn. Piper species have been used as an oriental medicinal plant for curing a wide range of diseases such as diarrhoea, gastric ailments and cholera in Chinese-, Indian-and pacific islands traditional medicines (17) . Piperine is a major bioactive compound reported to possess anti-cancer-, analgesic, anti-inflammatory-and anti-oxidant properties and is also used to increase bioavailability of drugs and nutrients (18) (19) (20) . Oral supplementation of piperine has been reported to suppress lung carcinogenesis in mice (21) . Vijayakumar et al. observed that piperine can reduce high-fat diet induced oxidative stress (22) . Piperine has been shown to increase plasma levels of orally supplemented coenzyme Q10 (23) . Moreover, piperine has also been demonstrated to inhibit cancer stem cell self-renewal properties (24).
Park et al. have demonstrated antiadipogenic properties of piperine in 3T3-L1 cells in vitro (25) . Although it is widely used and has an extensive range of pharmacological activities, little is known about the effects of piperine on osteoclastogenesis. Hence, we sought to analyze the potential effects of piperine on osteoclast formation. We provide first line of evidence that piperine has potential anti-osteoclastogenic effects by disruption of the p38/cFos/NFATc1 signaling axis and suppression of osteoclast function by disruption of cytoskeletal rearrangement.
Methods

Reagents
Dulbecco's Modified Eagle Medium (DMEM), α-MEM and heat-inactivated fetal bovine serum (FBS) were obtained from GIBCO (Grand Island, NY). Antibiotic-antimycotic solution containing 100 U/ml, penicillin, and total-NFATc1 antibodies were supplied by Cell Signaling Technology (Beverly, MA). Primary rabbit antibody against GAPDH was obtained from Abcam (Cambridge, MA) and goat anti-rabbit ALP-conjugated secondary antibody was procured from Life Technologies (Carlsbad, CA). 
Stock Solution
Alamar blue assay
Cells were seeded in 96-well plates and after 12h of attachment were exposed to increasing concentrations of piperine (20 µM, 40 µM, 80 µM and 100 µM). Alamar blue assay was conducted as per manufacturer's instructions (Life Technologies). Absorbance was measured at 570 nm with 600 nm as reference wavelength on a microplate reader (BioTek Instruments Inc., Winooski, VT).
Osteoclast differentiation and TRAP staining
RAW264.7 macrophages were differentiated into osteoclasts under the influence of RANKL for 5 days as described previously (27) . Briefly, cells were suspended in DMEM containing 10% FBS and seeded into sterile CD14+ monocytes were differentiated in the presence of M-CSF (25 ng/ml) and RANKL (30 ng/ml) for 14 days as described previously (26) .
Osteoclast specific TRAP staining was performed using a leucocyte acid-phosphatase kit as per manufacturer's directions (Sigma Aldrich, St Louis). TRAP+ cells with 3 or more nuclei were scored as osteoclasts.
Photomicrographs were taken with a Zeiss Axiocam MRc5 camera attached to a Zeiss Axiovert 40 CFL microscope (Carl Zeiss AG, Oberkochen, Germany).
Pit formation assay
The bone resorption function of RANKL-induced osteoclasts derived from RAW264.7 cells was analyzed using the osteoassay plates as per manufacturer's instructions (Corning Inc, New York). Resorption pits were observed under a light microscope and quantified by ImageJ software (28).
Isolation of human CD14+ monocytes and cell culture
Actin rings of osteoclasts were detected by staining actin filaments with Atto-conjugated phalloidin as described elsewhere (29) . Images were acquired using a fluorescence microscope (Carl Zeiss AG, Oberkochen, Germany).
Western blot analysis
Cell lysates were prepared using cell extraction buffer (Life Technologies, Carlsbad), supplemented with protease and phosphatase inhibitors (Sigma Aldrich, St Louis) and resolved on 12% SDS-PAGE gels. Purified proteins were quantified using a BCA protein assay kit as per manufacturer's directions (Sigma Aldrich, St Louis). Proteins were electrotransferred to nitrocellulose membranes with Tris-glycine transfer buffer [25 mM Tris, 192 mM glycine, 20% methanol (v/v)] probed with each antibody and detected by NBT/BCIP substrate. Digital images of the blots were acquired using a flatbed scanner (Ricoh Aficio, Johannesburg, South Africa). Band intensities were calculated using ImageJ software (28).
Statistical analysis
Data are representative of three independent experiments unless otherwise stated and are represented as mean ±standard deviation (SD). Statistical analysis was performed by one-way analysis of variance (ANOVA) followed by Bonferroni post hoc multiple comparison test using Graph Pad Prism Software (GraphPad Software Inc., CA).
P <0.05 was regarded as statistically significant.
Results
This study was conducted to analyze the effects of piperine (Fig. 1A ) on osteoclast formation induced by breast cancer cells and RANKL, as well as to investigate the effects of piperine on RANKL signaling involved in osteoclastogenesis. RAW264.7 murine macrophages and human CD14+ monocytes (henceforth referred as CD14+ monocytes) were used as osteoclast differentiation models for in vitro and ex vivo studies respectively.
Piperine does not affect the cell viability of RAW264.7 macrophages and CD14+ monocytes
RAW264.7 macrophages and CD14+ monocytes were treated with 20-100 µM of piperine for 48h, 72h and 96h to analyze cell viability by alamar blue assay. At tested concentrations, piperine did not exert cytotoxic effects on the studied cell lines (Fig. 1B, C) . Hence, these concentrations were chosen to study the effects of piperine in downstream experiments.
Piperine inhibits RANKL-induced osteoclastogenesis
RANKL is a major cytokine involved in the induction of osteoclastogenesis. Therefore, we investigated whether piperine can modulate osteoclast differentiation induced by RANKL. The osteoclast progenitor RAW264.7 macrophage cell line was treated with various concentrations (20-100 µM) of piperine in the presence or absence of RANKL and allowed to differentiate into osteoclasts for 5 days. As shown in Figure 2A , RANKL-treated cells differentiated into TRAP+ giant multinucleated osteoclasts. However, co-presence of piperine significantly reduced the differentiation of cells into osteoclasts. Furthermore, piperine mediated inhibition of osteoclastogenesis occurred in a dose-dependent manner (Fig. 2B) . As low as 80 µM piperine had a significant effect on RANKL-induced osteoclastogenesis in RAW264.7 macrophages.
Actin ring formation assay
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We next examined whether the anti-osteoclastogenic effects of piperine observed in murine macrophages in vitro could also be interpolated on human cells ex vivo in peripheral blood CD14+ monocytes. Results indicated that RANKL robustly induced osteoclast formation, whereas piperine inhibited this differentiation in a dose-dependent manner in CD14+ monocytes (Fig. 2C, D) .
Piperine mediated inhibition of RANKL-induced osteoclastogenesis correlates with the onset of osteoclast formation
To determine the onset of RANKL-induced osteoclast formation and analyze piperine mediated inhibition of osteoclastogenesis we followed the differentiation from days 3, 4 and 5. Stimulation of RAW264.7 macrophages with RANKL induced their differentiation into TRAP+ osteoclasts as early as day 3 as evidenced through morphological observations (Fig. 3A) . On the contrary, piperine exposure significantly attenuated RANKLinduced osteoclastogenesis. The extent of suppression was measured by counting the number of TRAP+ osteoclasts per well (Fig. 3B ) after days 3, 4, and 5. RANKL-induced osteoclast formation occurred in a timedependent manner with highest number of osteoclasts seen at day 5 ( Fig. 3B) . However, compared to cells treated with RANKL alone, piperine dose-dependently reduced the number of TRAP+ osteoclasts with maximum inhibition observed at 100 µM at all days examined.
Piperine inhibits RANKL-induced osteoclastogenesis at an early stage of differentiation
As seen in earlier experiments, osteoclasts first began to appear from the third day of RANKL exposure in RAW264.7 macrophages and completely differentiated into osteoclasts by the fifth day. To assess whether piperine-mediated inhibition of RANKL-induced osteoclastogenesis is time-dependent, we either treated cells together with RANKL and piperine at day 0 or initially treated the cells with RANKL alone, and piperine was added after days 1, 2, 3, or 4 ( Figure 4A , B). As seen in figure 4A , piperine suppressed osteoclast formation when added at day 0 or even after 1 or 2 days of RANKL addition. However, piperine did not affect osteoclast formation when supplemented after days 3 and 4 of RANKL stimulation (Fig.4) , indicating inhibitory effects of piperine at early stages of osteoclast differentiation.
Piperine inhibits actin ring formation and bone resorption
Actin ring formation and bone resorption are characterstic hallmarks of osteoclast. Treatment with RANKL induced fusion of RAW264.7 macrophages generating large osteoclasts with actin rings clearly seen as green fluorescence in figure 5A . On the contrary and in line with the osteoclast formation results RAW264.7 macrophages co-treated with piperine (100 µM) failed to fuse into osteoclasts and develop actin rings (Fig. 5A) .
Furthermore, owing to the attenuation of osteoclastogenesis and actin ring formation, RANKL and piperine (100 µM) co-treated cells did not form resorption pits (Fig. 5B, C) . However, RANKL treated cells clearly demonstrated bone resorptive activity (Fig. 5B, C ).
Piperine inhibits RANKL-induced activation of p38 MAP kinase pathway
To delineate the molecular mechanisms involved in piperine mediated inhibition of osteoclastogenesis we analysed activation of MAPKs and NF-κβ pathways at various time-points after RANKL stimulation. Treatment of RAW264.7 macrophages with RANKL led to a steep activation of these pathways as seen by western blot 8 through phosphorylation-specific antibodies (Fig. 6 ). Piperine markedly inhibited p38 activation whereas other signaling pathways including JNK, ERK and NF-κβ pathways remained unaffected (Fig. 6 ).
Piperine suppresses RANKL-induced c-Fos and NFATc1 expression
c-Fos and NFATc1 are crucial transcription factors induced at later stages of osteoclast signaling pathway. To analyse the effects of piperine on RANKL-mediated expression of these transcription factors western blotting was performed. As shown in figure 7A and B, RANKL potently induced the expression of c-Fos and NFATc1 as early as 12h and 24h respectively. However, co-exposure with piperine led to a drastic decrease in the expression levels of c-Fos and NFATc1 (Fig. 7A, B) .
Piperine inhibits osteoclastogenesis induced by breast cancer cells
Breast cancer metastasis to bone is associated with osteoclastogenesis and bone loss. To assess whether piperine can modulate breast cancer-induced osteoclastogenesis, we exposed RAW264.7 macrophages to 10% CM derived from MDA-MB-231 and MCF-7 human breast cancer cells. As shown in Fig. 8A , B incubation of RAW264.7
macrophages with CM derived from the breast cancer cells led to formation of osteoclasts after 7 days, and piperine suppressed this differentiation.
Piperine did not affect the viability of MC3T3-E1 osteoblast-like cells
Bone remodeling is a closely coupled process involving bone formation and resorption by osteoblasts and osteoclasts respectively. An ideal anti-osteoclastogenic compound should not affect the viability of osteoblasts.
To analyze the effects of piperine on the viability of murine MC3T3-E1 osteoblast like cells we further conducted an alamar blue assay. Treatment of MC3T3-E1 cells with piperine (20-100 µM) did not affect the viability of these cells (Fig. 9 ).
Discussion
Osteoclasts play an important role in bone remodeling by resorbing the old and deteriorating bone. However, during certain conditions such as osteoporosis and cancer metastasis of bone, overactivity of osteoclasts results in uncoupling of the remodeling process leading to excessive osteoclast activity and increased risk of fracture (30) .
In this study we assessed the effects of piperine on RANKL and breast cancer induced osteoclastogenesis in murine macrophage RAW264.7 cells and human CD14+ monocytes. Our results indicate that piperine inhibits the RANKL and breast cancer-induced osteoclastogenesis by attenuating the RANKL-mediated p38 activation and suppressing the expression of c-Fos and NFATc1 transcription factors. Furthermore, we also show that piperine acts at an early stage of osteoclast differentiation and does not affect the viability of osteoblast-like cells.
Osteoclasts originate from the monocyte/macrophage cells of the hematopoietic lineage (13) . Osteoclasts attach to the bone matrix and degrade the mineral and organic components of bone. Since, the last decade considerable information has been accumulated regarding signaling pathways and mechanisms involved in differentiation and activation of osteoclasts (31). RANKL is a major cytokine implicated in osteoclast formation and differentiation.
Unregulated RANKL signaling has been reported during various conditions such as ageing, osteoporosis, arthritis and cancer-induced bone loss (30, 5) . Natural products are a great source of efficacious and affordable lead 9 compounds for drug development (16) . Piperine, an alkaloid found in Piper nigrum Linn. is such a compound with several bioactive properties (32) .
Osteoclast formation is a multi-step process tightly regulated by the MAPKs (p38, JNK and ERK) and NF-κβ pathways leading to the induction and expression of c-Fos and NFATc1 (33, 8) . Especially, NFATc1 plays a key role at terminal stages of osteoclast differentiation (34) . Abrogation of any of these pathways severely alleviates osteoclast formation and bone resorption (35) (36) (37) . Our results demonstrate that piperine perturbed the RANKLinduced phosphorylation and activation of p38 MAPKs without affecting the activation of JNK, ERK and NF-κβ pathways. Earlier published studies have shown that p38-mediated pathway plays an indispensable role in osteoclast formation and pharmacological inhibition of p38 activation severely blunts osteoclastogenesis (35, 38) .
Moreover, p38 has been reported to be crucial for the induction of c-Fos and NFATc1 during RANKL-induced osteoclast formation (39) .
c-Fos is a critical transcription factor involved in osteoclastogenesis and induction of downstream genes related with osteoclast differentiation (40) . c-Fos knockout mice develop severe osteopetrotic phenotype with complete deficiency of osteoclasts (41, 42) . In the present study, we found that piperine drastically attenuated the RANKLinduced expression of c-Fos in osteoclast progenitors. It has been reported elsewhere that downregulation of cFos by 1, 25-dihydroxyvitamin D3 results in suppression of osteoclastogenesis (43) . Thus c-Fos is a crucial target for inhibiting osteoclastogenesis. NFATc1 is one of the most downstream transcription factors involved in osteoclast formation (34) . Expression of NFATc1 has been reported to occur downstream of c-Fos followed by auto-amplification of NFATc1 by its own activity (44, 34) . NFATc1 knockout mice completely lack osteoclasts and are osteopetrotic (34) . Our results in this study demonstrate that piperine negatively regulated the NFATc1 expression. Hence, the anti-osteoclastogenic effects of piperine could be due to its inhibition of p38 signaling pathway that consecutively led to the downregulated expression of c-Fos and NFATc1.
Breast cancer cells are reported to frequently migrate to bone and express proteins that aid in attachment to bone including chemokines (CXCR4) and increase osteolysis via osteoclasts (45) . Osteoclastogenesis has also been reported to be triggered by pathways alternative to RANKL such TNF-α induced osteoclastogenic pathway (46) .
Earlier lines of evidence suggest that breast cancer cell lines employed in this study (MDA-MB-231 and MCF-7)
do not express RANKL (47) . However, secretion of TNF-α in the conditioned medium of these cell lines has been 
